Seaborough Life Science

Seaborough Life Science invents and develops technologies to improve people’s well-being and health. Next to running a material research with the aim to enable novel therapies to treat certain skin diseases, our most recent activities are in the field of photobiomodulation, a science of certain biochemical interactions of light with living tissue.

Light therapy

The human body – and in particular the skin and the eyes – has many different interactions with light. Light therapy on the skin can be used to treat skin disorders, chiefly psoriasis, acne vulgaris, eczema and neonatal jaundice. Light can be used to reduce pain and accelerate wound healing. In addition light is also important in the generation of vitamin D3, which is amongst others important in preventing osteoporosis.

Light therapy which strikes the retina of the eyes is used to treat diabetic retinopathy and also circadian rhythm disorders such as delayed sleep phase disorder. It can also be used to treat seasonal affective disorder, with some support for its use also with non-seasonal psychiatric disorders.

Building on these proven therapies, Seaborough is constantly looking for new technologies in the field of lighting that contribute to human health.

Recent publications

Photobiomodulation: A New Dimension to Human Centric Lighting

Read the publication here

Article Dagblad van het Noorden: “Nanokristal als lichtomvormer” (Dutch)

Read the article here

Article Het Financieele Dagblad: “Seaborough fills the void left by Philips Lighting” (English)

Read the article here


Jürgen Honold